BUZZ - U.S. chip stocks fall again after briefly stabilizing in the previous session
路透社2026/10/22 12:47October 22 - ** After a brief rebound on Wednesday, US semiconductor stocks fell again in pre-market trading
** Chipmaker stocks declined: Nvidia NVDA.O dropped 2.1%, Advanced Micro Devices AMD.O fell 4.4%;
** Marvell MRVL.O, Applied Materials AMAT.O, and Intel INTC.O fell between 4.6% and 4.9%
** Lam Research LRCX.O declined by 7.2%, underperforming peers. Previously, the company forecast (link) second-quarter earnings would exceed expectations, but analysts believe supply chain shortages will delay growth, limiting upward revisions of earnings forecasts
** Memory chip manufacturer Micron (MU.O) fell 3%, while data storage company Western Digital (WDC.O) and SanDisk (SNDK.O) fell 3.3% and 4.1% respectively
** Texas Instruments (TXN.O) edged down 0.74%, with strong fourth-quarter revenue performance limiting the decline (link)
** Impacted by concerns related to artificial intelligence, chip stocks experienced heavy sell-offs last week and are attempting to rebound this week
** The Philadelphia Stock Exchange Semiconductor Index .SOX rose 3.3% week-to-date through Wednesday's close, after experiencing its sharpest weekly drop since March 2025 last week
** The index recorded its largest single-day gain in nearly three weeks in the previous trading session
** As of the previous trading session's close, the index .SOX has climbed more than 62% so far this year
(For the convenience of non-native English speakers, Reuters provides automated translations of its reports into several other languages. As automated translations may contain errors or lack the necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them only as a convenience to readers. Reuters accepts no liability for any damage or loss arising from the use of automated translation functions.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Gilead Sciences (GILD.US) acquires PepStar’s oral inflammation drug program for $1.275 billion in cash, increasing investment in inflammatory bowel disease pipeline
Gilead Sciences will acquire PepStar’s anti-inflammatory drug program for $1.28 billions.
Japan's core CPI rose 2.1% year-on-year in September, surpassing the central bank's 2% target for the first time in nine months! Broadening inflation strengthens expectations of a near-term rate hike.
Data released on Friday showed that Japan’s core Consumer Price Index (CPI) rose by 2.1% year-on-year in September, exceeding the Bank of Japan’s 2% inflation target for the first time in nine months. This indicates that price pressures are spreading and reinforces market expectations of an interest rate hike in the near future.

Heatbit launches a new home water heater that can mine Bitcoin

DoubleLine Capital: Large-Scale Borrowing and Weak Demand Will Continue to Put Pressure, Still Bearish on Long-Term U.S. Treasuries
DoubleLine Capital Deputy Chief Investment Officer Jeffrey Sherman stated that he remains bearish on long-term U.S. Treasury bonds, believing that large-scale government borrowing and weak demand will continue to put pressure on the U.S. Treasury market.
